OTCMKTS:ULGX - 21st North Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0080 0.00 (0.00 %)
(As of 11/18/2018 04:00 PM ET)
Previous Close$0.0080
Today's Range$0.0067 - $0.0080
52-Week Range$0.0011 - $0.15
Volume11,500 shs
Average Volume57,640 shs
Market Capitalization$170,000.00
P/E RatioN/A
Dividend YieldN/A
Urologix, Inc. develops, manufactures, markets, and distributes minimally invasive medical products for the treatment of obstruction and symptoms due to benign prostatic hyperplasia (BPH) in the United States. The company offers Cooled ThermoTherapy, which produces targeted microwave energy combined with a cooling mechanism to protect healthy tissue and enhance patient comfort. It also provides Prostiva RF Therapy System that delivers radio frequency energy directly into the prostate to destroy prostate tissue, reduce constriction of the urethra, and relieve BPH symptoms. It serves patients and clinicians. Urologix, Inc. was founded in 1991 and is based in Minneapolis, Minnesota.

Receive ULGX News and Ratings via Email

Sign-up to receive the latest news and ratings for ULGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Electromedical equipment
Current SymbolOTCMKTS:ULGX
Previous Symbol


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A


Outstanding Shares21,820,000
Market Cap$170,000.00
OptionableNot Optionable

21st North (OTCMKTS:ULGX) Frequently Asked Questions

What is 21st North's stock symbol?

21st North trades on the OTCMKTS under the ticker symbol "ULGX."

How were 21st North's earnings last quarter?

21st North Inc (OTCMKTS:ULGX) issued its quarterly earnings data on Thursday, February, 5th. The company reported ($0.02) EPS for the quarter. The business earned $3.10 million during the quarter, compared to the consensus estimate of $3.80 million. View 21st North's Earnings History.

Has 21st North been receiving favorable news coverage?

Press coverage about ULGX stock has trended somewhat positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. 21st North earned a news impact score of 1.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the near future.

Who are some of 21st North's key competitors?

Who are 21st North's key executives?

21st North's management team includes the folowing people:
  • Bryon Merade, Chairman & CEO

How do I buy shares of 21st North?

Shares of ULGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is 21st North's stock price today?

One share of ULGX stock can currently be purchased for approximately $0.0080.

How big of a company is 21st North?

21st North has a market capitalization of $170,000.00.

What is 21st North's official website?

The official website for 21st North is http://www.urologix.com.

How can I contact 21st North?

21st North's mailing address is 14405 21ST AVE N, MINNEAPOLIS MN, 55447. The company can be reached via phone at 612-475-1400 or via email at [email protected]

MarketBeat Community Rating for 21st North (OTCMKTS ULGX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  30 (Vote Outperform)
Underperform Votes:  25 (Vote Underperform)
Total Votes:  55
MarketBeat's community ratings are surveys of what our community members think about 21st North and other stocks. Vote "Outperform" if you believe ULGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ULGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel